NDA Group will be attending PEGS Europe, that takes place in EPIC SANA Lisboa Hotel, Lisbon Portugal 13-17 November, 2017.
NDA supported over 40% of the new medicinal products that were approved in the EU during 2013 -2016. In 2016 NDA acquired PharmApprove, the market leader in managing critical FDA interactions to help us achieve the same results in the US.
If you are planning to attend this year’s PEGS, we would really like to meet up with you. We will have a few of our experts available at the event:
- Dr Paula Salmikangas, Director of Biopharmaceuticals and ATMPs, NDA Advisory Board
- Dr Niamh Kinsella, Biologics Expert
- Dr Jenny Sims, Non Clinical Expert
- Dr Josefin-Beate Holz, Clinical Strategy Expert
If you would like to arrange a meeting, please contact Niamh Kinsella, who will be happy to assist, firstname.lastname@example.org
Three of our experts will present at the event.
Monday 13th, Tuesday 14th November, Poster Session A
Developing an Integrated Summary of Immunogenicity (ISI) to Effectively Manage Regulatory Risks in Product Development
Click here to find out more about the event.
We look forward to hearing back from you about a meeting and to seeing you at the event!